Literature DB >> 12576920

Paraneoplastic Raynaud phenomenon and idiopathic thrombocytopenic purpura in non-small-cell lung cancer.

Alvin S C Wong1, Kam Hon Yoon.   

Abstract

The association of Raynaud phenomenon with malignancy has rarely been reported. Idiopathic thrombocytopenic purpura is also an infrequent complication of solid tumors. We report a 62-year-old man who sought treatment for severe Raynaud phenomenon requiring medical therapy and was subsequently diagnosed to have non-small-cell lung cancer. After chemotherapy and radiotherapy, his cancer was in complete remission and the Raynaud phenomenon resolved. Severe thrombocytopenia later developed for which no apparent cause was found, and which was responsive to steroid therapy. This heralded relapse of his lung cancer. This is a case of lung cancer with two rare paraneoplastic syndromes.

Entities:  

Mesh:

Year:  2003        PMID: 12576920     DOI: 10.1097/00000421-200302000-00006

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  4 in total

1.  Paraneoplastic Raynaud's phenomenon manifesting before the diagnosis of lung cancer.

Authors:  Irappa Madabhavi; Swaroop Revannasiddaiah; Madhup Rastogi; Manoj Kumar Gupta
Journal:  BMJ Case Rep       Date:  2012-07-03

2.  Acquired rhinophyma as a paraneoplastic manifestation of non-small cell lung cancer.

Authors:  Neven Rakusic; Denis Baricevic; Nevena Rakusic; Miroslav Samarzija; Marko Jakopovic; Marinka Baricevic
Journal:  Wien Klin Wochenschr       Date:  2012-04-14       Impact factor: 1.704

3.  Paraneoplastic Raynaud's Phenomenon as an Initial Manifestation of Lung Cancer?

Authors:  Sravani Lokineni; Mahesh Nepal; Amr Mohamed
Journal:  Eur J Case Rep Intern Med       Date:  2021-07-09

4.  Association between systemic sclerosis, palmar fasciitis with polyarthritis, Raynaud's phenomenon and erythromelalgia with underlying malignancy.

Authors:  Katarzyna Nowak; Gary Wright
Journal:  Reumatologia       Date:  2022-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.